Scientists have provided evidence of a protein that inhibits the hepatitis C virus at an early stage of its infective cycle.

This research suggests possible new perspectives for the development of therapies to block the virus before it enters a cell.

Hepatitis C is a major public health problem that affects some 130 million people throughout the world.